Indoco Remedies Limited (INDOCO.NS)
Makes and sells medicines and pharmaceutical ingredients for hospitals and patients across India
225.05-0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-27.3%
The outlook
Indoco Remedies is trading near its lower half of its 52-week range and below both its 50- and 200-day moving averages, signaling a weaker near-term trend. Analyst consensus leans Hold with thin coverage, and the average price target sits roughly 17% above the current price. The stock carries a notably elevated trailing P/E ratio, which warrants attention when evaluating valuation.
What’s behind the score
Analyst consensusHold — 3.0 avg of 4 analysts
Price trendBelow its 50- & 200-day averages
52-week range37% of the way from its 52-week low to high
Price targetAvg target +17% vs current price
Analyst price target
~12-month · 4 analysts264.00average target+17.3% vs now
Now 225.05
Low 231.00High 325.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$20.74B
52-wk high
332.20
52-wk low
162.19
50-day avg
229.77
200-day avg
225.28
Trailing P/E
703.3